Europe Neurovascular Catheters Market Size, Share & Industry Trends Analysis Report By Type, By End-Use (Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers), By Application, By Country and Growth Forecast, 2023 - 2029

Europe Neurovascular Catheters Market Size, Share & Industry Trends Analysis Report By Type, By End-Use (Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers), By Application, By Country and Growth Forecast, 2023 - 2029

The Europe Neurovascular Catheters Market would witness market growth of 6.4% CAGR during the forecast period (2023-2029).

The market is experiencing growth due to the rising demand for a more natural and aesthetically pleasing appearance across all age groups, as well as a reduction in blood loss during minimally invasive surgeries. Implementing such procedures can enhance the patient experience by reducing trauma and promoting faster recovery compared to invasive procedures. Minimally invasive neurovascular procedures are expected to experience an increase in demand due to the benefits of neurovascular catheters, such as reduced blood loss and faster recovery time.

The demand for endoscopic brain surgery, which has increased as a result of the continuing advancement of endoscopic surgical procedures and single-incision laparoscopic, is a significant factor that is driving the market. Because of these improvements, conventional approaches to brain surgery will no longer be utilized, which will lead to an increase in the need for neurovascular catheters and other equipment utilized in the practice of neurovascular medicine.

The cases of the brain aneurysms in Europe are experiencing growth due to the rising incidence of neurological disorders and increased efforts in research and development to enhance product innovation for improved diagnosis. Also, the incidence of brain aneurysms is increasing in several European nations. Moreover, governments are launching strategic initiatives which are aimed at treating patients with a brain aneurysm.

In the United Kingdom, brain aneurysms affect approximately 2-3% of the population. The prevalence of this condition is higher among women than men and is more frequently observed in the adult population. The incidence rate of subarachnoid hemorrhage caused by aneurysms in the UK is estimated to be around 7 cases per 100,000 individuals with sporadic aneurysms. Thus, the growing cases of brain aneurysm in the region, with regional authorities introducing initiatives to treat, and control the disease, the utilization of neurovascular catheters are expected to increase for treatment, driving the market expansion in the region.

The Germany market dominated the Europe Neurovascular Catheters Market by Country in 2022; thereby, achieving a market value of $319.2 million by 2029. The UK market is poised to grow at a CAGR of 5.5% during (2023 - 2029). Additionally, The France market would showcase a CAGR of 7.2% during (2023 - 2029).

Based on Type, the market is segmented into Embolization Catheters, Access Catheters, Balloon Catheters, Microcatheters and Others. Based on End-Use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers. Based on Application, the market is segmented into Brain Aneurysm, Embolic Stroke, Arteriovenous Malformations and Hydrolysate. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Terumo Corporation, Integer Holdings Corporation, Penumbra, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Integra LifeSciences Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, RAUMEDIC AG (REHAU Industries SE & Co. KG)

Scope of the Study

Market Segments covered in the Report:

By Type

Embolization Catheters
Access Catheters
Balloon Catheters
Microcatheters
Others
By End Use

Hospitals
Clinics
Ambulatory Surgical Centers
Diagnostic Centers
By Application

Brain Aneurysm
Embolic Stroke
Arteriovenous Malformations
Hydrolysate
By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Companies Profiled

Medtronic PLC
Stryker Corporation
Terumo Corporation
Integer Holdings Corporation
Penumbra, Inc.
Johnson & Johnson (Johnson & Johnson Services, Inc.)
Integra LifeSciences Corporation
Acandis GmbH
Spiegelberg GmbH & Co. KG
RAUMEDIC AG (REHAU Industries SE & Co. KG)
Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free